# RHYTHM PHARMACEUTICALS, INC. (RYTM) FY2026 Q2 Statement of Cash Flows

- Company: RHYTHM PHARMACEUTICALS, INC. (RYTM)
- Period: 2026-04-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-04, accession number 0001628280-26-052533
- Page: https://plicit.ai/financials/rytm/fy2026-q2-cash-flow
- Chart image: https://plicit.ai/charts/rytm-fy2026-q2-cash-flow-sankey.png

## Chart details

Cash flows for Apr 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations. Beginning cash: Mar 31, 2026. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

- **Beginning cash on Mar 31, 2026**: 62,738,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
- **Operating activities**: negative 9,152,000 US dollars. Net cash used.
- **Net loss**: negative 49,298,000 US dollars
- **Stock-based compensation expense**: 26,056,000 US dollars
- **Depreciation and amortization**: 251,000 US dollars
- **Non-cash interest expense**: 4,539,000 US dollars
- **Non-cash accretion & amortization of short-term investments**: negative 1,174,000 US dollars
- **Non-cash rent expense**: 119,000 US dollars
- **Change in fair value of embedded derivative liability**: 230,000 US dollars
- **Foreign currency (gain) loss**: negative 1,015,000 US dollars
- **Accounts receivable**: negative 6,216,000 US dollars
- **Inventory**: negative 2,342,000 US dollars
- **Prepaid expenses and other current assets**: 2,804,000 US dollars
- **Deferred revenue**: negative 49,000 US dollars
- **Other long-term assets, net**: 0 US dollars
- **Accounts payable, accrued expenses and other liabilities**: 16,456,000 US dollars
- **Other non-cash items**: 487,000 US dollars
- **Investing activities**: 14,013,000 US dollars. Net cash provided.
- **Purchases of short-term investments**: negative 43,486,000 US dollars
- **Maturities of short-term investments**: 57,499,000 US dollars
- **Financing activities**: negative 1,165,000 US dollars. Net cash used.
- **Repayment of deferred royalty obligation**: negative 6,907,000 US dollars
- **Proceeds from the exercise of stock options**: 6,999,000 US dollars
- **Proceeds from issuance of common stock from ESPP**: 0 US dollars
- **Proceeds from ATM equity offering**: 0 US dollars
- **Tax withholding on vesting of restricted stock**: negative 1,257,000 US dollars
- **Operating adjustment reconciliation**: 60,094,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- **financing gross reconciliation**: 8,164,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **investing gross reconciliation**: 57,499,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **Exchange-rate effect**: negative 217,000 US dollars
- **Ending cash on Jun 30, 2026**: 66,217,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash, including disposal groups and discontinued operations
- **Cash sources and uses**: 76,751,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- **Net cash change**: 3,479,000 US dollars. Ending cash minus beginning cash.
- **Cash flow / Net income**: Not meaningful. Operating cash flow divided by reconciliation net income for the same period. The ratio is not meaningful when net income is zero or negative.

### Chart connections

- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net loss −$49.30M + net operating adjustments $40.15M = operating cash −$9.15M. The loss reduces the earnings basis of the reconciliation; it is not a cash payment. The signed loss remains a deduction at the operating reconciliation junction.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.